CARE — Dialogue Health Technologies Share Price
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall Cap
- CA$346.67m
- CA$293.87m
- CA$87.13m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.54 | ||
| Price to Tang. Book | 3.76 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.66 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -22.61% | ||
| Return on Equity | -19.23% | ||
| Operating Margin | -24.14% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 4.01 | 10.09 | 35.8 | 64.53 | 87.13 | 108.1 | 133.08 | 115.86% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Dialogue Health Technologies Inc. is a Canada-based telemedicine company. The Company provides a digital healthcare and wellness platform, namely the Integrated Health Platform. The Company’s Integrated Health Platform is a healthcare hub that centralizes all its programs in a single application by providing access to service all the 365 days through a smartphone, computer or tablet. Through the Company’s vertically integrated platform, its members and their dependents have access to a team of multidisciplinary professionals who treats physical and mental health conditions as well as other wellness services. It also offers its members and their dependents access to an employee assistance program (EAP), as well as an Internet-based cognitive behavioral therapy (iCBT) program. Its wellness program includes clinically reviewed content, wellness challenges (integrated with wearable technology) and healthy habits, to help members sleep better, reduce stress, improve fitness and nutrition.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- March 31st, 2023
- Incorporated
- July 5th, 2016
- Public Since
- March 30th, 2021
- No. of Employees
- 240
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Toronto Stock Exchange
- Shares in Issue
- 67,189,866
- Address
- 390 Notre-Dame W, Suite 200, MONTREAL, H2Y 1T9
- Web
- https://dialogue.co/
- Phone
- Auditors
- Deloitte LLP
Upcoming Events for CARE
Q3 2023 Dialogue Health Technologies Inc Earnings Release
Similar to CARE
Akumin
Toronto Stock Exchange
Aleafia Health
Toronto Stock Exchange
Andlauer Healthcare
Toronto Stock Exchange
Avant Brands
Toronto Stock Exchange
dentalcorp Holdings
Toronto Stock Exchange
FAQ
What is the Dialogue Health Technologies share price?
As of Today at 01:07 UTC, shares in Dialogue Health Technologies are trading at CA$3.60. This share price information is delayed by 15 minutes.
How has the Dialogue Health Technologies share price performed this year?
Shares in Dialogue Health Technologies last closed at CA$3.60 and the price had moved by +17.65% over the past 365 days. In terms of relative price strength the Dialogue Health Technologies share price has outperformed the Toronto Stock Exchange 300 Composite Index by +8.61% over the past year.
What are the analyst and broker recommendations for Dialogue Health Technologies?
The overall consensus recommendation for Dialogue Health Technologies is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Dialogue Health Technologies dividend yield?
Dialogue Health Technologies does not currently pay a dividend.
Does Dialogue Health Technologies pay a dividend?
Dialogue Health Technologies does not currently pay a dividend.
When does Dialogue Health Technologies next pay dividends?
Dialogue Health Technologies does not currently pay a dividend.
How do I buy Dialogue Health Technologies shares?
To buy shares in Dialogue Health Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Dialogue Health Technologies?
As of the previous close price of CA$3.60, shares in Dialogue Health Technologies had a market capitalisation of CA$342.00m.
Where are Dialogue Health Technologies shares listed?
Here are the trading details for Dialogue Health Technologies:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: CARE
What kind of share is Dialogue Health Technologies?
Based on an overall assessment of its quality, value and momentum Dialogue Health Technologies is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Dialogue Health Technologies share price forecast for 2023?
The analyst consensus target price for shares in Dialogue Health Technologies is CA$3.47. That is 3.54% below the last closing price of CA$3.60.
Analysts covering Dialogue Health Technologies currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.14 for the next financial year.
What is the trend in the Dialogue Health Technologies share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Dialogue Health Technologies. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -0.59%.
As of the last closing price of CA$3.60, shares in Dialogue Health Technologies were trading +11.21% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Dialogue Health Technologies PE Ratio?
The Dialogue Health Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$3.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Dialogue Health Technologies?
Dialogue Health Technologies' management team is headed by:
- Cherif Habib - CEO
- Alexis Smirnov - CFD
- Anna Chif - CFD
- Navaid Mansuri - CFO
- Jean-Nicolas Guillemette - COO